Advanz Pharma
fund manager
sector
Healthcare
geography
Europe
Vintages
status
Portfolio
category
#ImpactPositive

Advanz Pharma

Co-invested company
Since 1963, Advanz Pharma has been producing and marketing medical treatments for rare and orphan diseases.
Consulting room representing Advanz Pharma, part of the Private Equity manager's portfolio Nordic Capital

Advanz Pharma key figures

665 M€
Turnover in 2022
630
employees
17
sites on 3 continents
4.4 billion
recovery in 2023
*Source: Public data from company websites and social networks. For the most up-to-date information, we invite our investors to consult the reports available in their own space.

About Advanz Pharma

Present in over 90 countries worldwide, the company is committed to designing drugs neglected by the major pharmaceutical companies, ranging from endocrinology to pulmonary infections and hepatology.

Advanz Pharma is a market leader, successfully reaching niche targets on 4 continents. Advanz Pharma's expertise in the treatment of rare diseases is well established, and the company will have more than 300 pharmaceutical partners by 2023.

Advanz Pharma's aim is therefore to continue asserting its dominant position in the rare drugs market, but also to focus on innovation in order to broaden its spectrum of action and reach a wider audience.

In the same sector as Advanz Pharma

Discover our exclusive services
Nordic Capital
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio